Drug Search Results
More Filters [+]

Olpadronic acid

Alternative Names: olpadronic acid
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action: Osteoclast Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Gador
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Olpadronic acid

Countries in Clinic:

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Chronic Pain|Low Back Pain

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2015-004269-96

P2

Active, not recruiting

Chronic Pain|Low Back Pain

2017-08-24

Recent News Events

Date

Type

Title